Novogene Co., Ltd. (SHA:688315)
China · Delayed Price · Currency is CNY 16.72
+0.02 (0.12%)
Aug 12, 2025, 2:45 PM CST
H&E Equipment Services Market Cap
Novogene has a market cap or net worth of 6.77 billion as of August 12, 2025. Its market cap has increased by 58.91% in one year.
Market Cap
6.77B
Enterprise Value
5.34B
Revenue
2.14B
Ranking
n/a
PE Ratio
34.39
Stock Price
$16.72
Market Cap Chart
Since April 13, 2021, Novogene's market cap has decreased from 10.97B to 6.77B, a decrease of -38.24%. That is a compound annual growth rate of -10.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 6.77B | 33.76% |
| Dec 31, 2024 | 5.06B | -47.88% |
| Dec 29, 2023 | 9.71B | -8.02% |
| Dec 30, 2022 | 10.56B | -36.10% |
| Dec 31, 2021 | 16.53B | 50.73% |
| Apr 13, 2021 | 10.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 406.93B |
| Shenzhen Mindray Bio-Medical Electronics | 279.02B |
| WuXi AppTec | 264.87B |
| Zhangzhou Pientzehuang Pharmaceutical., | 120.83B |
| Aier Eye Hospital Group | 118.61B |
| Sichuan Biokin Pharmaceutical | 118.48B |
| Shanghai United Imaging Healthcare | 107.18B |
| Yunnan Baiyao Group Co.,Ltd | 99.72B |